Genetic deletion of DLK1 in ACC dramatically downregulates ABCB1 and increases ADC payload and chemotherapy sensitivity through NOTCH1-mediated transdifferentiation. The gene discussed is DLK1; the disease is adrenal cortex carcinoma.